Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

Title
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 381, Issue 25, Pages 2416-2428
Publisher
Massachusetts Medical Society
Online
2019-12-19
DOI
10.1056/nejmoa1911361

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started